IHL used to sell CBD Oils, similar to that of ASX:AGH through Cannvalate in the past.
We were gaining momentum fast, and were 2nd or 3rd largest in revenues in a very short period of time but chose to get rid of that part of the business to focus solely on drug development.
We are a biotech company, with CBD based drugs that will go all the way i.e GW Pharma. Not the crock of BS that you will see across the entire ASX. I believe only BOT is going the route of FDA approved trials. Everything else iirc is FLUFF.
We also are a psychedelics company, like our US Peers MindMed, Compass Pathways and ATAI.
Consider us drug development only, generic CBD oils are a race to the bottom.
IHL Price at posting:
35.5¢ Sentiment: Buy Disclosure: Held